Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by deployment
1.4.2. Market size breakdown, by end user
1.4.3. Market size breakdown, by application
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Global Market
6.1. Overview
6.2. Market Revenue, by Deployment (2017–2030)
6.3. Market Revenue, by End User (2017–2030)
6.4. Market Revenue, by Application (2017–2030)
6.5. Market Revenue, by Region (2017–2030)
Chapter 7. North America Market
7.1. Overview
7.2. Market Revenue, by Deployment (2017–2030)
7.3. Market Revenue, by End User (2017–2030)
7.4. Market Revenue, by Application (2017–2030)
7.5. Market Revenue, by Country (2017–2030)
Chapter 8. Europe Market
8.1. Overview
8.2. Market Revenue, by Deployment (2017–2030)
8.3. Market Revenue, by End User (2017–2030)
8.4. Market Revenue, by Application (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. APAC Market
9.1. Overview
9.2. Market Revenue, by Deployment (2017–2030)
9.3. Market Revenue, by End User (2017–2030)
9.4. Market Revenue, by Application (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. LATAM Market
10.1. Overview
10.2. Market Revenue, by Deployment (2017–2030)
10.3. Market Revenue, by End User (2017–2030)
10.4. Market Revenue, by Application (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. MEA Market
11.1. Overview
11.2. Market Revenue, by Deployment (2017–2030)
11.3. Market Revenue, by End User (2017–2030)
11.4. Market Revenue, by Application (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. U.S. Market
12.1. Overview
12.2. Market Revenue, by Deployment (2017–2030)
12.3. Market Revenue, by End User (2017–2030)
12.4. Market Revenue, by Application (2017–2030)
Chapter 13. Canada Market
13.1. Overview
13.2. Market Revenue, by Deployment (2017–2030)
13.3. Market Revenue, by End User (2017–2030)
13.4. Market Revenue, by Application (2017–2030)
Chapter 14. Germany Market
14.1. Overview
14.2. Market Revenue, by Deployment (2017–2030)
14.3. Market Revenue, by End User (2017–2030)
14.4. Market Revenue, by Application (2017–2030)
Chapter 15. France Market
15.1. Overview
15.2. Market Revenue, by Deployment (2017–2030)
15.3. Market Revenue, by End User (2017–2030)
15.4. Market Revenue, by Application (2017–2030)
Chapter 16. U.K. Market
16.1. Overview
16.2. Market Revenue, by Deployment (2017–2030)
16.3. Market Revenue, by End User (2017–2030)
16.4. Market Revenue, by Application (2017–2030)
Chapter 17. Italy Market
17.1. Overview
17.2. Market Revenue, by Deployment (2017–2030)
17.3. Market Revenue, by End User (2017–2030)
17.4. Market Revenue, by Application (2017–2030)
Chapter 18. Spain Market
18.1. Overview
18.2. Market Revenue, by Deployment (2017–2030)
18.3. Market Revenue, by End User (2017–2030)
18.4. Market Revenue, by Application (2017–2030)
Chapter 19. Japan Market
19.1. Overview
19.2. Market Revenue, by Deployment (2017–2030)
19.3. Market Revenue, by End User (2017–2030)
19.4. Market Revenue, by Application (2017–2030)
Chapter 20. China Market
20.1. Overview
20.2. Market Revenue, by Deployment (2017–2030)
20.3. Market Revenue, by End User (2017–2030)
20.4. Market Revenue, by Application (2017–2030)
Chapter 21. India Market
21.1. Overview
21.2. Market Revenue, by Deployment (2017–2030)
21.3. Market Revenue, by End User (2017–2030)
21.4. Market Revenue, by Application (2017–2030)
Chapter 22. Australia Market
22.1. Overview
22.2. Market Revenue, by Deployment (2017–2030)
22.3. Market Revenue, by End User (2017–2030)
22.4. Market Revenue, by Application (2017–2030)
Chapter 23. South Korea Market
23.1. Overview
23.2. Market Revenue, by Deployment (2017–2030)
23.3. Market Revenue, by End User (2017–2030)
23.4. Market Revenue, by Application (2017–2030)
Chapter 24. Brazil Market
24.1. Overview
24.2. Market Revenue, by Deployment (2017–2030)
24.3. Market Revenue, by End User (2017–2030)
24.4. Market Revenue, by Application (2017–2030)
Chapter 25. Mexico Market
25.1. Overview
25.2. Market Revenue, by Deployment (2017–2030)
25.3. Market Revenue, by End User (2017–2030)
25.4. Market Revenue, by Application (2017–2030)
Chapter 26. Saudi Arabia Market
26.1. Overview
26.2. Market Revenue, by Deployment (2017–2030)
26.3. Market Revenue, by End User (2017–2030)
26.4. Market Revenue, by Application (2017–2030)
Chapter 27. South Africa Market
27.1. Overview
27.2. Market Revenue, by Deployment (2017–2030)
27.3. Market Revenue, by End User (2017–2030)
27.4. Market Revenue, by Application (2017–2030)
Chapter 28. U.A.E. Market
28.1. Overview
28.2. Market Revenue, by Deployment (2017–2030)
28.3. Market Revenue, by End User (2017–2030)
28.4. Market Revenue, by Application (2017–2030)
Chapter 29. Competitive Landscape
29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments
Chapter 30. Company Profiles
30.1. Stryker Corporation
30.1.1. Business overview
30.1.2. Product and service offerings
30.1.3. Key financial summary
30.2. Zimmer Biomet Holdings Inc.
30.2.1. Business overview
30.2.2. Product and service offerings
30.2.3. Key financial summary
30.3. Medtronic Plc
30.3.1. Business overview
30.3.2. Product and service offerings
30.3.3. Key financial summary
30.4. Brainlab AG
30.4.1. Business overview
30.4.2. Product and service offerings
30.4.3. Key financial summary
30.5. mediCAD Hectec GmbH
30.5.1. Business overview
30.5.2. Product and service offerings
30.5.3. Key financial summary
30.6. 3D Systems Corporation
30.6.1. Business overview
30.6.2. Product and service offerings
30.6.3. Key financial summary
30.7. Renishaw Plc
30.7.1. Business overview
30.7.2. Product and service offerings
30.7.3. Key financial summary
Chapter 31. Appendix
31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports
| ※参考情報 術前計画ソフトウェアは、外科手術の準備と実施を円滑に行うための重要なツールです。これらのソフトウェアは、手術に関する情報を整理・分析し、計画の質を向上させるために利用されます。最終的な目標は、患者の安全性を確保し、手術の成功率を高めることです。 術前計画ソフトウェアには、いくつかの種類があります。最も一般的なものの一つは、画像処理ソフトウェアです。これにより、CTやMRIといった医療画像をもとに、三次元モデルを作成することができます。これらのモデルを用いることで、外科医は解剖学的な情報を視覚的に理解しやすくなります。また、手術予定部位の正確な位置関係を把握することができ、手術中の誤解を避けることができます。 また、シミュレーションソフトウェアも重要な役割を果たしています。これにより、外科医は手術手技を事前にシュミレーションし、様々なシナリオを試すことができます。この技術により、外科医は手術中に直面する可能性のある課題を予め把握し、対策を講じることが可能になります。患者ごとに異なる解剖学的特徴を考慮しながら、最適な手術手順を選定することができます。 さらに、術前計画ソフトウェアは、データ管理の機能も提供します。手術に関するさまざまなデータを蓄積し、解析することができます。過去の手術データや患者の病歴、治療計画を組み合わせることで、より効果的な術前計画が立てられます。このようなデータの活用は、医療の質の向上につながります。 術前計画ソフトウェアの用途は多岐にわたります。特に、腫瘍切除や移植手術、整形外科手術など、多くの分野で利用されています。腫瘍切除では、腫瘍の大きさや位置を詳細に分析し、周囲の組織への影響を最小限に抑える計画が立てられます。また、整形外科的な手術においても、関節の位置や角度を正確に把握することで、手術後の機能回復に寄与します。 術前計画ソフトウェアの関連技術として、人工知能(AI)や機械学習が挙げられます。AI技術を用いることで、膨大なデータからパターンを見出し、手術の成功率を向上させるための新たな手法を提供します。AIは、患者の個別特性に基づいた予測を行い、手術計画の精度を高める手助けをします。特に、医療画像解析においてAIが導入されることで、より迅速で正確な診断が可能となります。 また、3Dプリンティング技術も術前計画において重要な役割を果たしています。患者ごとの解剖学的特徴をもとに、手術に必要な器具やインプラントのモデルを作成することができます。これにより、外科医は実際の手術に近い状態で手技を練習することができ、より実践的な手術が可能となります。 術前計画ソフトウェアは、医療現場においてますます重要なツールとなってきています。医療の進歩に伴い、術前計画の精度や効率が求められる中、これらのソフトウェアは外科医にとって不可欠な存在です。今後も技術が進化し、さらなる効率化や安全性の向上が期待されます。術前計画ソフトウェアは、外科手術の未来を変える可能性を秘めているのです。これらの技術の進展により、患者に提供される医療サービスが向上し、ひいては医療全体の質が向上することが期待されます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

